Establishment of a Lifetime of Cohort of Adults Surviving Childhood Cancer
NCT00760656 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2026-04-23
Summary
Childhood cancer predisposes to health risks that may not become apparent until many years after completion of therapy. The SJLIFE protocol is designed to establish a lifetime cohort of childhood cancer survivors treated at St. Jude Children's Research Hospital to facilitate evaluation of health outcomes in aging adults surviving pediatric cancer.
The study focuses on the following Primary and secondary objectives:
* To establish a lifetime cohort of childhood cancer survivors treated at St. Jude Children's Research Hospital to facilitate evaluation of health outcomes in aging children and adults surviving pediatric cancer.
* To estimate the prevalence, cumulative incidence, and latency of selected late treatment complications following predisposing therapeutic exposures in children and adults surviving pediatric cancer.
* To identify treatment, demographic, and psychosocial / behavioral related predictors of adverse health outcomes.
* To develop risk profiles for adverse health outcomes across the age spectrum to guide development of clinical screening guidelines and risk-reducing interventions.
* To identify factors that may be protective against the development of specific late treatment complications.
* To generate data for a series of future hypothesis-driven trials
* To serve as a source for the collection of samples from child and adult volunteers for future SJLIFE research.
* To collect health outcomes data on a community control population for comparison purposes.
* Characterize longitudinal social determinants of health (SDOH) to examine how living conditions, social integration, and structural inequality interact with personal social integrations/support to influence health.
Conditions
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
American Society of Clinical Oncology
collaborator OTHER -
Rally Foundation
collaborator UNKNOWN -
Memorial Sloan Kettering Cancer Center
collaborator OTHER - collaborator OTHER
-
St. Baldrick's Foundation
collaborator OTHER -
American Institute for Cancer Research
collaborator OTHER -
American Cancer Society, Inc.
collaborator OTHER -
St. Jude Children's Research Hospital
lead OTHER
Principal Investigators
-
Melissa Hudson, MD · St. Jude Children's Research Hospital
Eligibility
- Min Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-09-13
- Primary Completion
- 2035-12-31
- Completion
- 2035-12-31
Countries
- United States
Study Locations
More Related Trials
-
Feasibility of Screening for Early Late Effects of Contemporary Therapy in High-Risk Neuroblastoma Survivors
NCT06480526 ·Status: ACTIVE_NOT_RECRUITING
-
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
NCT05535166 ·Status: RECRUITING ·Phase: PHASE2
-
Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children
NCT06099366 ·Status: RECRUITING ·Phase: PHASE2
-
Exploring The Role Of Palliative Care In Phase 1 Enrolled Pediatric Oncology Patients
NCT05412563 ·Status: TERMINATED
-
Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases
NCT00001686 ·Status: COMPLETED
-
Learning Impairments Among Survivors of Childhood Cancer
NCT00576472 ·Status: COMPLETED ·Phase: PHASE4
-
MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia
NCT01231919 ·Status: COMPLETED ·Phase: PHASE1
-
Tumor Rebiopsy in Children and Adolescents With Recurrent or Progressive Solid Malignancies
NCT03276702 ·Status: COMPLETED
-
Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
NCT01962103 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
NCT03117751 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma
NCT00336024 ·Status: COMPLETED ·Phase: PHASE3
-
Therapy for Pediatric Hodgkin Lymphoma
NCT00145600 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment
NCT04928677 ·Status: RECRUITING ·Phase: PHASE1
-
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
NCT04901702 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors
NCT04023669 ·Status: COMPLETED ·Phase: PHASE1
-
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor
NCT00003273 ·Status: WITHDRAWN ·Phase: PHASE2
-
High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood
NCT00180791 ·Status: UNKNOWN ·Phase: PHASE2
-
Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia
NCT00022737 ·Status: COMPLETED ·Phase: PHASE3
-
Individualized High Dose Methotrexate to Treat Cancer in Children Who Have a Significant Risk for Side Effects to Methotrexate
NCT02076997 ·Status: COMPLETED ·Phase: NA
-
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
NCT02847130 ·Status: COMPLETED
-
A Study of Pemetrexed in Children With Recurrent Cancer
NCT00520936 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
NCT05004116 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.
NCT07017816 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
SU5416 in Treating Children With Recurrent or Progressive Brain Tumors
NCT00006247 ·Status: TERMINATED ·Phase: PHASE1
-
The Decision To Enroll In Therapeutic Clinical Trials In A Pediatric Cancer Clinical Network
NCT05454618 ·Status: RECRUITING